|
1
|
Nestle FO, Kaplan DH and Barker J:
Psoriasis. N Engl J Med. 361:496–509. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gudjonsson JE and Elder JT: Psoriasis:
Epidemiology. Clin Dermatol. 25:535–546. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Huang RY, Li L, Wang MJ, Chen XM, Huang QC
and Lu CJ: An Exploration of the role of MicroRNAs in psoriasis: A
systematic review of the literature. Medicine (Baltimore).
94:e20302015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ortega C, Fernández-A S, Carrillo JM,
Romero P, Molina IJ, Moreno JC and Santamaría M: IL-17-producing
CD8+ T lymphocytes from psoriasis skin plaques are
cytotoxic effector cells that secrete Th17-related cytokines. J
Leukoc Biol. 86:435–443. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ross K: Towards topical microRNA-directed
therapy for epidermal disorders. J Control Release. 269:136–147.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Soltanzadeh-Yamchi M, Shahbazi M, Aslani S
and Mohammadnia-Afrouzi M: MicroRNA signature of regulatory T cells
in health and autoimmunity. Biomed Pharmacother. 100:316–323. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ruksha TG, Komina AV and Palkina NV:
MicroRNA in skin diseases. Eur J Dermatol. 27:343–352.
2017.PubMed/NCBI
|
|
8
|
Liu Y and Liu Q: MicroRNAs as regulatory
elements in psoriasis. Open Med (Wars). 11:336–340. 2016.PubMed/NCBI
|
|
9
|
Barca-Mayo O and Lu QR: Fine-tuning
oligodendrocyte development by microRNAs. Front Neurosci. 6:132012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hawkes JE, Nguyen GH, Fujita M, Florell
SR, Callis Duffin K, Krueger GG and O'Connell RM: microRNAs in
psoriasis. J Invest Dermatol. 136:365–371. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jiang M, Sun Z, Dang E, Li B, Fang H, Li
J, Gao L, Zhang K and Wang G: TGFβ/SMAD/microRNA-486-3p signaling
axis mediates keratin 17 expression and keratinocyte
hyperproliferation in psoriasis. J Invest Dermatol. 137:2177–2186.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Degueurce G, D'Errico I, Pich C, Ibberson
M, Schütz F, Montagner A, Sgandurra M, Mury L, Jafari P, Boda A, et
al: Identification of a novel PPARβ/δ/miR-21-3p axis in UV-induced
skin inflammation. EMBO Mol Med. 8:919–936. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Boele J, Persson H, Shin JW, Ishizu Y,
Newie IS, Søkilde R, Hawkins SM, Coarfa C, Ikeda K, Takayama K, et
al: PAPD5-mediated 3 adenylation and subsequent degradation of
miR-21 is disrupted in proliferative disease. Proc Natl Acad Sci
USA. 111:11467–11472. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guinea-Viniegra J, Jiménez M, Schonthaler
HB, Navarro R, Delgado Y, Concha-Garzón MJ, Tschachler E, Obad S,
Daudén E and Wagner EF: Targeting miR-21 to treat psoriasis. Sci
Transl Med. 6:225re12014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Masalha M, Sidi Y and Avni D: The
contribution of feedback loops between miRNAs, cytokines and growth
factors to the pathogenesis of psoriasis. Exp Dermatol. 27:603–610.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Stepicheva NA and Song JL: Function and
regulation of microRNA-31 in development and disease. Mol Reprod
Dev. 83:654–674. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yan S, Xu Z, Lou F, Zhang L, Ke F, Bai J,
Liu Z, Liu J, Wang H, Zhu H, et al: NF-κB-induced microRNA-31
promotes epidermal hyperplasia by repressing protein phosphatase 6
in psoriasis. Nat Commun. 6:76522015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu N, Meisgen F, Butler LM, Han G, Wang
XJ, Söderberg-Nauclér C, Ståhle M, Pivarcsi A and Sonkoly E:
MicroRNA-31 is overexpressed in psoriasis and modulates
inflammatory cytokine and chemokine production in keratinocytes via
targeting serine/threonine kinase 40. J Immunol. 190:678–688. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hermann H, Runnel T, Aab A, Baurecht H,
Rodriguez E, Magilnick N, Urgard E, Šahmatova L, Prans E,
Maslovskaja J, et al: miR-146b probably assists miRNA-146a in the
suppression of keratinocyte proliferation and inflammatory
responses in psoriasis. J Invest Dermatol. 137:1945–1954. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ichihara A, Jinnin M, Yamane K, Fujisawa
A, Sakai K, Masuguchi S, Fukushima S, Maruo K and Ihn H:
microRNA-mediated keratinocyte hyperproliferation in psoriasis
vulgaris. Br J Dermatol. 165:1003–1010. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zibert JR, Løvendorf MB, Litman T, Olsen
J, Kaczkowski B and Skov L: MicroRNAs and potential target
interactions in psoriasis. J Dermatol Sci. 58:177–185. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Srivastava A, Nikamo P, Lohcharoenkal W,
Li D, Meisgen F, Xu Landén N, Ståhle M, Pivarcsi A and Sonkoly E:
MicroRNA-146a suppresses IL-17-mediated skin inflammation and is
genetically associated with psoriasis. J Allergy Clin Immunol.
139:550–561. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pivarcsi A, Ståhle M and Sonkoly E:
Genetic polymorphisms altering microRNA activity in psoriasis - a
key to solve the puzzle of missing heritability? Exp Dermatol.
23:620–624. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Guo Q, Zhang J, Li J, Zou L, Zhang J, Xie
Z, Fu X, Jiang S, Chen G, Jia Q, et al: Forced miR-146a expression
causes autoimmune lymphoproliferative syndrome in mice via
downregulation of Fas in germinal center B cells. Blood.
121:4875–4883. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xia P, Fang X, Zhang ZH, Huang Q, Yan KX,
Kang KF, Han L and Zheng ZZ: Dysregulation of miRNA146a versus
IRAK1 induces IL-17 persistence in the psoriatic skin lesions.
Immunol Lett. 148:151–162. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chatzikyriakidou A, Voulgari PV, Georgiou
I and Drosos AA: The role of microRNA-146a (miR-146a) and its
target IL-1R-associated kinase (IRAK1) in psoriatic arthritis
susceptibility. Scand J Immunol. 71:382–385. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shams K, Kurowska-Stolarska M, Schütte F,
Burden AD, McKimmie CS and Graham GJ: MicroRNA-146 and cell trauma
down-regulate expression of the psoriasis-associated atypical
chemokine receptor ACKR2. J Biol Chem. 293:3003–3012. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hou RX, Liu RF, Zhao XC, Jia YR, An P, Hao
ZP, Li JQ, Li XH, Yin GH and Zhang KM: Increased miR-155-5p
expression in dermal mesenchymal stem cells of psoriatic patients:
Comparing the microRNA expression profile by microarray. Genet Mol
Res. Sep 2–2016.(Epub ahead of print). doi: 10.4238/gmr.15038631.
View Article : Google Scholar
|
|
29
|
García-Rodríguez S, Arias-Santiago S,
Blasco-Morente G, Orgaz-Molina J, Rosal-Vela A, Navarro P,
Magro-Checa C, Martínez-López A, Ruiz JC, Raya E, et al: Increased
expression of microRNA-155 in peripheral blood mononuclear cells
from psoriasis patients is related to disease activity. J Eur Acad
Dermatol Venereol. 31:312–322. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xu L and Leng H, Shi X, Ji J, Fu J and
Leng H: miR-155 promotes cell proliferation and inhibits apoptosis
by PTEN signaling pathway in the psoriasis. Biomed Pharmacother.
90:524–530. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xu Y, Ji Y, Lan X, Gao X, Chen HD and Geng
L: miR 203 contributes to IL 17 induced VEGF secretion by targeting
SOCS3 in keratinocytes. Mol Med Rep. 16:8989–8996. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Primo MN, Bak RO, Schibler B and Mikkelsen
JG: Regulation of pro-inflammatory cytokines TNFα and IL24 by
microRNA-203 in primary keratinocytes. Cytokine. 60:741–748. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xu N, Brodin P, Wei T, Meisgen F, Eidsmo
L, Nagy N, Kemeny L, Ståhle M, Sonkoly E and Pivarcsi A: miR-125b,
a microRNA downregulated in psoriasis, modulates keratinocyte
proliferation by targeting FGFR2. J Invest Dermatol. 131:1521–1529.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wei T, Folkersen L, Biskup E, Xu N, Manfe
V, Niazi O and Gniadecki R: Ubiquitin-specific peptidase 2 as a
potential link between microRNA-125b and psoriasis. Br J Dermatol.
176:723–731. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang MJ, Xu YY, Huang RY, Chen XM, Chen
HM, Han L, Yan YH and Lu CJ: Role of an imbalanced miRNAs axis in
pathogenesis of psoriasis: Novel perspectives based on review of
the literature. Oncotarget. 8:5498–5507. 2017.PubMed/NCBI
|
|
36
|
Lerman G, Avivi C, Mardoukh C, Barzilai A,
Tessone A, Gradus B, Pavlotsky F, Barshack I, Polak-Charcon S,
Orenstein A, et al: MiRNA expression in psoriatic skin: Reciprocal
regulation of hsa-miR-99a and IGF-1R. PLoS One. 6:e209162011.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lerman G, Sharon M, Leibowitz-Amit R, Sidi
Y and Avni D: The crosstalk between IL-22 signaling and miR-197 in
human keratinocytes. PLoS One. 9:e1074672014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Elharrar E, Masalha M, Lerman G,
Leibowitz-Amit R, Kassem R, Harats M, Sidi Y and Avni D:
Positive-negative feedback loop between MiR-197 and IL-17A
signaling in human keratinocytes. Immunome Res. May 2–2016.(Epub
ahead of print). doi: 10.4172/1745-7580.10000111. View Article : Google Scholar
|
|
39
|
Wang R, Zhao Z, Zheng L, Xing X, Ba W,
Zhang J, Huang M, Zhu W, Liu B, Meng X, et al: MicroRNA-520a
suppresses the proliferation and mitosis of HaCaT cells by
inactivating protein kinase B. Exp Ther Med. 14:6207–6212.
2017.PubMed/NCBI
|
|
40
|
Wang X, Wang P, Zhu Y, Zhang Z, Zhang J
and Wang H: MicroRNA-520a attenuates proliferation of Raji cells
through inhibition of AKT1/NF-κB and PERK/eIF2α signaling pathway.
Oncol Rep. 36:1702–1708. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Van Gele M, Bracke S, de Medeiros Alves AK
and Lambert J: Exploring the feasibility of whole blood to identify
systemic miRNA biomarkers for patients with moderate to severe
psoriasis. Eur J Dermatol. 26:195–198. 2016.PubMed/NCBI
|
|
42
|
Liu Q, Wu DH, Han L, Deng JW, Zhou L, He
R, Lu CJ and Mi QS: Roles of microRNAs in psoriasis: Immunological
functions and potential biomarkers. Exp Dermatol. 26:359–367. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sonkoly E, Wei T, Janson PC, Sääf A,
Lundeberg L, Tengvall-Linder M, Norstedt G, Alenius H, Homey B,
Scheynius A, et al: MicroRNAs: Novel regulators involved in the
pathogenesis of psoriasis? PLoS One. 2:e6102007. View Article : Google Scholar : PubMed/NCBI
|
